Gene editing to treat genetic diseases, Part II

The following is an edited excerpt. 

Duchenne muscular dystrophy (DMD) and its milder form, Becker muscular dystrophy (BMD), are genetic disorders affecting approximately one in 3,500 new born males. Individuals with DMD have a life expectancy of about 25 years on average, and current estimates place the prevalence of DMD at about 300,000 individuals worldwide.

Researchers are working to use sequence-specific DNA binding proteins to create new tools for targeted genome editing. These tools may allow researchers to correct mutations that cause sever genetic diseases by specifically cutting any DNA sequence.

Read the full story here: Gene Editing to Treat Genetic Diseases, Part II

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend